Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.

Literature DB >> 11326037

Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.

K J Watts¹, C H Thompson, Y E Cossart, B R Rose.

Abstract

The functional significance of sequence variation within the upstream regulatory region (URR) of six human papillomavirus type 16 (HPV16) cervical cancer isolates from Australia was investigated. Specific changes in transcription factor binding sites leading to increased promoter activity may explain the transforming ability of some episomal HPV16 isolates.

Entities: Disease Species

Mesh：

Substances：

Year: 2001 PMID： 11326037 PMCID： PMC88072 DOI： 10.1128/JCM.39.5.2009-2014.2001

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

17 in total

1. The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element.

Authors: M J O'Connor; W Stünkel; C H Koh; H Zimmermann; H U Bernard
Journal: J Virol Date: 2000-01 Impact factor: 5.103

2. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity.

Authors: Christina Kämmer; Ursula Warthorst; Norah Torrez-Martinez; Cosette M Wheeler; Herbert Pfister
Journal: J Gen Virol Date: 2000-08 Impact factor: 3.891

3. The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1.

Authors: G J Sibbet; S Cuthill; M S Campo
Journal: J Virol Date: 1995-07 Impact factor: 5.103

4. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions.

Authors: B C Das; J K Sharma; V Gopalakrishna; U K Luthra
Journal: J Gen Virol Date: 1992-09 Impact factor: 3.891

5. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.

Authors: X P Dong; F Stubenrauch; E Beyer-Finkler; H Pfister
Journal: Int J Cancer Date: 1994-09-15 Impact factor: 7.396

6. Firefly luciferase gene: structure and expression in mammalian cells.

Authors: J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal: Mol Cell Biol Date: 1987-02 Impact factor: 4.272

7. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind.

Authors: S Y Chan; L Ho; C K Ong; V Chow; B Drescher; M Dürst; J ter Meulen; L Villa; J Luande; H N Mgaya
Journal: J Virol Date: 1992-04 Impact factor: 5.103

8. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.

Authors: T Ishiji; M J Lace; S Parkkinen; R D Anderson; T H Haugen; T P Cripe; J H Xiao; I Davidson; P Chambon; L P Turek
Journal: EMBO J Date: 1992-06 Impact factor: 11.598

9. The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding.

Authors: G Steger; J Ham; O Lefebvre; M Yaniv
Journal: EMBO J Date: 1995-01-16 Impact factor: 11.598

10. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.

Authors: M May; X P Dong; E Beyer-Finkler; F Stubenrauch; P G Fuchs; H Pfister
Journal: EMBO J Date: 1994-03-15 Impact factor: 11.598

5 in total

Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.

1. The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element.

2. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity.

3. The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1.

4. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions.

5. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.

6. Firefly luciferase gene: structure and expression in mammalian cells.

7. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind.

8. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.

9. The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding.

10. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.

Review 1. HPV infections and tonsillar carcinoma.

2. Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.

Review 3. HPV & head and neck cancer: a descriptive update.

4. hpvPDB: An Online Proteome Reserve for Human Papillomavirus.

5. Sequence variation in the E2-binding domain of HPV16 and biological function evaluation in Tunisian cervical cancers.